Add to ORKGThe need for a right ventricular assist device following an implantable left ventricular assist device creates a complex situation for the surgeon, nursing staff, and the patient. The purpose of this report is to describe the rationale, technical, and perioperative issues of a hybrid ventricular assist device consisting of a Heartmate XVE (Thoratec, Inc., Pleasonton, CA) left ventricular assist device and Abiomed AB5000 right ventricular assist device (Abiomed, Inc., Danvers, MA)
Right ventricular failure continues to be the Achilles heel in the management of heart failure patie...
We report a case of HeartMate II® left ventricular assist device (LVAD) implantation as a destinatio...
ObjectiveThe Thoratec (Thoratec Corp, Pleasanton, Calif) implantable ventricular assist device (IVAD...
The need for a right ventricular assist device following an implantable left ventricular assist devi...
Until recently, right ventricular failure following implantation of a left ventricular assist device...
Congestive heart failure is the leading cause of hospitalization and death in the developed world an...
While left ventricular assist devices (LVADs) are common treatment for patients with heart failure, ...
In patients with refractory end-stage heart failure, cardiac transplantation remains the only establ...
Given the limited availability of donor hearts, ventricular assist device (VAD) therapy is fast beco...
Recent outstanding clinical advances with new mechanical circulatory systems have led to additional ...
Refractory right ventricular failure (RVF) after implantation of left ventricular assist device (LVA...
DisclosureThis presentation describes the off-label use of the Centrimag™ Ventricular Assist Device ...
Systemic right ventricular failure is a common finding in patients with transposition of the great a...
We describe three successful cases of HeartMate(R)left ventricular assist device (LVAD; Thermo Cardi...
The optimal treatment option for end stage heart failure is transplantation; however, the shortage o...
Right ventricular failure continues to be the Achilles heel in the management of heart failure patie...
We report a case of HeartMate II® left ventricular assist device (LVAD) implantation as a destinatio...
ObjectiveThe Thoratec (Thoratec Corp, Pleasanton, Calif) implantable ventricular assist device (IVAD...
The need for a right ventricular assist device following an implantable left ventricular assist devi...
Until recently, right ventricular failure following implantation of a left ventricular assist device...
Congestive heart failure is the leading cause of hospitalization and death in the developed world an...
While left ventricular assist devices (LVADs) are common treatment for patients with heart failure, ...
In patients with refractory end-stage heart failure, cardiac transplantation remains the only establ...
Given the limited availability of donor hearts, ventricular assist device (VAD) therapy is fast beco...
Recent outstanding clinical advances with new mechanical circulatory systems have led to additional ...
Refractory right ventricular failure (RVF) after implantation of left ventricular assist device (LVA...
DisclosureThis presentation describes the off-label use of the Centrimag™ Ventricular Assist Device ...
Systemic right ventricular failure is a common finding in patients with transposition of the great a...
We describe three successful cases of HeartMate(R)left ventricular assist device (LVAD; Thermo Cardi...
The optimal treatment option for end stage heart failure is transplantation; however, the shortage o...
Right ventricular failure continues to be the Achilles heel in the management of heart failure patie...
We report a case of HeartMate II® left ventricular assist device (LVAD) implantation as a destinatio...
ObjectiveThe Thoratec (Thoratec Corp, Pleasanton, Calif) implantable ventricular assist device (IVAD...